Delivery Order SPE2DB24D8003-SPE2DB25FJUGP
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$8.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,567,720,329 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The $6,259.23 contract has a performance period ending on March 28, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which allows the company to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,027.24 firm fixed price contract is for the delivery of 4,563,197,924 units of Methylphenidate ER 27 mg tablets in 100 count packages. This contract has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA...
The Defense Logistics Agency (DLA) awarded a $5,476.61 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,321,317 units of Methylphenidate ER 18 mg tablets. This order falls under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,567,223,219 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The contract has a firm fixed price of $3,300.05 and a period of performance through February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4566327375 - Methylphenidate ER 36 MG Tablets in 100 count bottles. The contract has a ceiling value of $1,664.43 and a period of performance through November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001, held by Dakota Drug, Inc. under the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 100 bottles of 30mg extended-release methylphenidate tablets to support military medical operations. The contract has a total ceiling value of $1,424.57 and a period of performance through October 16, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract valued at $7,836.12 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of 4,564,544,485 units of methylphenidate extended-release 27 mg tablets. The contract has an ultimate completion date of May 9, 2024 and is not set aside. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products, medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,937.66 firm fixed-price contract is for the supply of 4,564,042,715 units of the pharmaceutical product Methylphenidate ER 27 mg tablets with an ultimate completion date of March 22, 2024. No set-aside was used for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal government,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...